INDBInternet News Database 2.5 Updated 1 min ago · 293 sources Show or hide images Light or dark

Cutaneous Sarcoidosis Could Soon Get an Effective Therapy

2 sources2 articles First seen Updated United States Truth score 48

Save Like Comments Compare coverage
Image from Medpagetoday

Summary

(MedPage Today) -- ORLANDO -- Patients with cutaneous sarcoidosis -- a condition with no very effective therapy -- saw dramatic improvement with the dual-acting TYK2/JAK1 inhibitor brepocitinib (Lisraya) in a small phase II trial. Patients...

Description from Medpagetoday.

Who is covering this

  1. Medscape Center Factuality: Mostly factual US
    Brepocitinib Improves Cutaneous Sarcoidosis in Phase 2

    In a phase 2 trial, oral brepocitinib improves skin disease activity and quality of life in adults with cutaneous sarcoidosis.

  2. Medpagetoday Center Factuality: Mostly factual US
    Cutaneous Sarcoidosis Could Soon Get an Effective Therapy

    (MedPage Today) -- ORLANDO -- Patients with cutaneous sarcoidosis -- a condition with no very effective therapy -- saw dramatic improvement with the dual-acting TYK2/JAK1 inhibitor brepocitinib (Lisraya) in a small phase II trial. Patients...

Comments

Comments need JavaScript.